Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET

Rhea-AI Summary

Harvard Bioscience (Nasdaq: HBIO) has scheduled its third quarter 2024 financial results announcement for November 7, 2024, before market opening. The company will host a conference call at 8:00 AM ET to discuss the results. Participants wanting to ask questions must pre-register to receive dial-in information and a PIN. An audio-only webcast option is also available through the company's investor website, where the earnings release and related presentation materials will be accessible.

HOLLISTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2024 before the market opens on November 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. 

Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number. 

Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.

Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website. 

About Harvard Bioscience 

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.

For more information, please visit our website at www.harvardbioscience.com.

Company Contact:
Jennifer Cote
Chief Financial Officer
(508) 893-3120

Investors Contact:
Three Part Advisors
Sandy Martin
HBIO@threepa.com
(214) 616-2207

FAQ

When will Harvard Bioscience (HBIO) release Q3 2024 earnings?

Harvard Bioscience will release its Q3 2024 earnings before market opens on November 7, 2024.

What time is Harvard Bioscience's (HBIO) Q3 2024 earnings call?

The earnings conference call is scheduled for 8:00 AM Eastern Time on November 7, 2024.

How can investors join Harvard Bioscience's (HBIO) Q3 2024 earnings call?

Investors must pre-register to receive dial-in numbers and a PIN for asking questions, or they can join the audio-only webcast through the company's investor website.